3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow VNP 20009: new trials by email Literature Review of VNP 20009 trials Research Report on VNP 20009
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VNP20009 in Treating Patients With Advanced Solid Tumors salmonella VNP20009 - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Vion Pharmaceuticals | 2000-05-01 | 2013-07-18 | |
| Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria VNP20009 - Cancer, Neoplasm | Phase 1 | Completed | National Cancer Institute (NCI) | 45 | 2000-03-01 | 2008-03-04 |
| VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy salmonella VNP20009, cefixime, ceftriaxone sodium - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Vion Pharmaceuticals | 1999-08-01 | 2013-07-18 |
Neoplasm Metastasis (1) · Neoplasms (1)
Vion Pharmaceuticals (2) · National Cancer Institute (NCI) (1)
United States (3)
Mario Sznol, MD (2)